Evidence map›Paper›PMID 37008734›Full record

ArticleAsian journal of pharmaceutical sciences2023

Mesoporous silica nanoparticles with chiral pattern topological structure function as "antiskid tires" on the intestinal mucosa to facilitate oral drugs delivery.

Wei Xin, Lin Wang, Jiahui Lin, Yanbu Wang, Qi Pan, Yang Han, Zhiye Bao, Shun Zong, Ying Cheng, Xuchun Chen and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Asian journal of pharmaceutical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Wei XinSchool of Pharmacy, China Medical University, Shenyang 110122, China.
Lin WangSchool of Pharmacy, China Medical University, Shenyang 110122, China.
Jiahui LinSchool of Pharmacy, China Medical University, Shenyang 110122, China.
Yanbu WangSchool of Pharmacy, China Medical University, Shenyang 110122, China.
Qi PanThe First Hospital of China Medical University, Shenyang 110001, China.
Yang HanThe First Hospital of China Medical University, Shenyang 110001, China.
Zhiye BaoThe First Hospital of China Medical University, Shenyang 110001, China.
Shun ZongSchool of Pharmacy, China Medical University, Shenyang 110122, China.
Ying ChengThe First Hospital of China Medical University, Shenyang 110001, China.
Xuchun ChenThe First Hospital of China Medical University, Shenyang 110001, China.
Lin ZhaoSchool of Pharmacy, China Medical University, Shenyang 110122, China.
Heran LiSchool of Pharmacy, China Medical University, Shenyang 110122, China.
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The weak adhesion between nanocarriers and the intestinal mucosa was one of the main reasons caused the failure in oral delivery. Inspired by the "antiskid tires" with complex chiral patterns, mesoporous silica nanoparticles AT-R@CMSN exhibiting geometrical chiral structure were designed to improve the surface/interface roughness in nanoscale, and employed as the hosting system for insoluble drugs nimesulide (NMS) and ibuprofen (IBU). Once performing the delivery tasks, AT-R@CMSN with rigid skeleton protected the loaded drug and reduced the irritation of drug on gastrointestinal tract (GIT), while their porous structure deprived drug crystal and improved drug release. More importantly, AT-R@CMSN functioned as "antiskid tire" to produce higher friction on intestinal mucosa and substantively influenced multiple biological processes, including "contact", "adhesion", "retention", "permeation" and "uptake", compared to the achiral S@MSN, thereby improving the oral adsorption effectiveness of such drug delivery systems. By engineering AT-R@CMSN to overcome the stability, solubility and permeability bottlenecks of drugs, orally administered NMS or IBU loaded AT-R@CMSN could achieve higher relative bioavailability (705.95% and 444.42%, respectively) and stronger anti-inflammation effect. In addition, AT-R@CMSN displayed favorable biocompatibility and biodegradability. Undoubtedly, the present finding helped to understand the oral adsorption process of nanocarriers, and provided novel insights into the rational design of nanocarriers.

Indexed as

Bio-adhesionChiral mesoporous silicaIntestinal mucosaNanocarrier designOral delivery

Identifiers

PMID37008734
PMCPMC10060614
OpenAlexW4321769394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.